ADE LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$686K Buy
593
+6
+1% +$7.08K 0.28% 42
2026
Q2
$704K Hold
587
– – 0.3% 42
2026
Q1
$540K Hold
587
– – 0.26% 49
2025
Q4
$631K Sell
587
-52
-8% -$49.7K 0.31% 45
2025
Q3
$488K Buy
639
+378
+145% +$281K 0.25% 53
2025
Q2
$203K Sell
261
-14
-5% -$10.9K 0.11% 77
2025
Q1
$227K Hold
275
– – 0.13% 69
2024
Q4
$212K Buy
275
+16
+6% +$13.2K 0.13% 80
2024
Q3
$229K Hold
259
– – 0.14% 76
2024
Q2
$234K Hold
259
– – 0.16% 75
2024
Q1
$201K Buy
+259
New +$184K 0.14% 79
2021
Q4
– Sell
-250
Closed -$58K – 159
2021
Q3
$58K Hold
250
– – 0.05% 119
2021
Q2
$57K Buy
+250
New +$50.2K 0.05% 128

Other funds holding LLY

ADE LLC's LLY Position: Q3 2026 in Review

ADE LLC increased its Eli Lilly (LLY) stake by 1% in Q3 2026, buying an estimated $7.08K and bringing the position to 593 shares worth $686K. The position accounts for 0.28% of the portfolio, ranked #42.

ADE LLC first reported a position in LLY in Q2 2021 and has held it in 13 quarters since. The position peaked at $704K in Q2 2026. 2,556 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • ADE LLC held 593 shares of Eli Lilly worth $686K as of Q3 2026.
  • ADE LLC bought 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
  • Eli Lilly made up 0.28% of ADE LLC's portfolio in Q3 2026, its #42 holding.
  • ADE LLC first reported a position in Eli Lilly in Q2 2021 and has held it in 13 quarters since.
  • ADE LLC's Eli Lilly position peaked at $704K in Q2 2026.
  • 2,556 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on ADE LLC's 13F filing for Q3 2026, filed 29 Oct 2026.